VIMSELTINIB vs VISMODEGIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
VIMSELTINIB vs VISMODEGIB: Safety Overview
| Metric | VIMSELTINIB | VISMODEGIB |
|---|---|---|
| Total FAERS Reports | 170 | 8,135 |
| Deaths Reported | 0 | 864 |
| Death Rate | N/A | 10.6% |
| Hospitalizations | 5 | 974 |
| Average Patient Age | 45.6 yrs | 69.6 yrs |
| % Female Patients | 55.4% | 39.3% |
| FDA Approval Date | Feb 14, 2025 | Jan 30, 2012 |
| Manufacturer | Deciphera Pharmaceuticals, LLC | Genentech, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |